Scientific publications

Download hieronder

Nabongo P, Verver S, Nangobi E, Mutunzi R, Wajja A, Mayanja-Kizza H, Kadobera D, Galiwango E, Colebunders R, Musoke P.

BMC Public Health 2014;14(1):314.

Abstract  http://www.biomedcentral.com/1471-2458/14/314/abstract

Nwokoye N, Onubogu C, Nwadike O, Abiodun A, Onwujekwe D, Gidado M, Olubi O, Idigbe O.

Open Science Journal of Clinical Medicine 2014;2(2): 59-62.

Onazi O, Abdurrahman S, Van der Grinten E, Onazi M, Oyama E, Gidado M, Omoniyi AF.

Journal of Health Science 2 (2014) 152-156.

Solomon T, Shiferaw M, Abraham W, Tayu B, Klinkenberg E, Loha E.

PHA 2014;4 Suppl. 3.

Tesgaye F, Defar A, Beyene T, Shafi O, Klinkenberg E, Howe R.

PHA 2014;4 Suppl. 3.

Trajman A, Durovni B, Saraceni V, Cordeiro-Santos M, Cobelens F, van den Hof S.

Eur Respir J. 2014. pii: erj01155-2014.

Abstract   http://high%20positive%20predictive%20value%20of%20xpert%20in%20a%20low%20rifampicin%20resistance%20prevalence%20setting./

Uppada DR, Selvam S, Jesuraj N, Bennett S, Verver S, Grewal H, Vaz M and TB Trials Study Group.

BMC Infectious Diseases.2014, 14:571

Van Hest NAH, Bakker M, Keizer ST, van der Wall E, Huisman EM, de Vries G.

Tijdschr Infect 2014;9(6):172-6

De Beer JL, van Ingen J, de Vries G, Erkens C, Sebek M, Mulder A, Sloot R, van den Brandt AM, Enaimi M, Kremer K, Supply P, van Soolingen D.

J Clin Microbiol 2013;51(4):1193-8.

Abstract http://www.ncbi.nlm.nih.gov/pubmed/?term=beer+vries+soolingen

Diel R, Loddenkemper R, Zellweger JP, Sotgiu G, D’Ambrosio L, Centis R, van der Werf MJ, Dara M, Detjen A, Gondrie P, Reichman L, Blasi F, Migliori GB.

Eur Respir J 2013;42(3):785-801.

Abstract http://www.ncbi.nlm.nih.gov/pubmed/?term=Old+ideas+to+innovate+TB+control%3A+preventive+treatment+to+achieve+elimination.

Diel R, Vandeputte J, de Vries G, Stillo J, Wanlin M, Nienhaus A.

Eur Respir J 2013 [Epub ahead of print].

Abstract http://www.ncbi.nlm.nih.gov/pubmed/23949960

Overzicht alle informatie KNCV Kennisbank

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us